IONS News

IONS SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Ionis Pharmaceuticals, Inc. For Possible Securities Law Violations

IONS Investor Alert: Levi & Korsinsky Investigates Ionis Pharmaceuticals, Inc. (IONS) for Potential Securities Fraud

Ionis Pharmaceuticals, Inc. (IONS) Faces Investor Scrutiny After Surprise Trial Failure Drives Stock Down 23% – HBSS

Levi & Korsinsky Notifies Investors of a Pending Investigation Into Securities Claims Involving Ionis Pharmaceuticals (IONS)

Ionis Partner Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease

IONS SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Ionis Pharmaceuticals, Inc. For Possible Securities Law Violations

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS

IONS Investor Alert: Levi & Korsinsky Notifies Investors of an Investigation Into Ionis Pharmaceuticals (IONS)

Ionis doses first participant in Phase 1-2 ASCEND study of ION337 in Dravet syndrome

Levi & Korsinsky Announces Investigation of Securities Claims Against Ionis Pharmaceuticals, Inc. (IONS)